Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Ephedrine to Reduce Fetal Bradycardia After CSE Labor Analgesia
NCT02062801Phase 4Completed
- Sponsor
- Sharp HealthCare
- Start
- Jan 2012
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ephedrine in fetal bradycardia, sponsored by Sharp HealthCare. Started Jan 2012; status: completed.
02
Drugs
ephedrine
03
Conditions
fetal bradycardia
Beyond the preview
Go deeper on NCT02062801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02062801.